XML 15 R5.htm IDEA: XBRL DOCUMENT v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities:    
Net income $ 34,644 $ 39,235
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 19,342 18,077
Provision for credit losses 3,016 2,753
Stock-based compensation expense 5,681 5,857
Deferred income tax expense 3,536 3,308
Amortization of intangibles 982 926
Amortization of debt issuance costs 389 384
Amortization and accretion of debt 440 420
Loss on extinguishment of debt 579 0
Net loss on divestitures and impairment charges 48 788
Net gain on sale of excess real property 0 (1,047)
Changes in operating assets and liabilities that provided (used) cash:    
Accounts and preneed receivables (8,925) (18,405)
Inventories, prepaid, and other current assets (7,199) 203
Intangible and other non-current assets (3,817) (2,100)
Preneed funeral and cemetery trust investments (4,608) (16,796)
Accounts payable (5,017) (3,477)
Accrued and other liabilities (6,941) (1,493)
Deferred preneed funeral and cemetery revenue 8,419 623
Deferred preneed funeral and cemetery receipts held in trust 6,628 17,312
Net cash provided by operating activities 47,197 46,568
Cash flows from investing activities:    
Acquisitions of businesses (6,007) (56,499)
Capital expenditures (15,069) (12,715)
Proceeds from divestitures and sale of other assets 982 37,310
Net cash used in investing activities (20,094) (31,904)
Cash flows from financing activities:    
Borrowings from the credit facility 184,879 113,800
Payments against the credit facility (196,829) (115,900)
Payment of debt issuance costs for the credit facility (1,280) 0
Payments on acquisition debt and obligations under finance leases (607) (427)
Proceeds from the exercise of stock options and employee stock purchase plan contributions 916 1,476
Taxes paid on restricted stock, performance award vestings, and exercise of stock options (2,383) (8,276)
Dividends paid on common stock (5,342) (5,254)
Net cash used in financing activities (20,646) (14,581)
Net increase in cash and cash equivalents 6,457 83
Cash and cash equivalents at beginning of period 1,688 1,165
Cash and cash equivalents at end of period 8,145 1,248
Supplemental disclosure of cash flow information:    
Cash paid for interest and financing costs 15,217 15,840
Cash paid for income taxes $ 13,419 $ 10,820